Edwards Lifesciences
Financial Performance
Edwards Lifesciences Revenue & Financials
Revenue
$6B (FY2024)
Market Cap
$42B
Net Income
$1.4B
Employees
19,000
What is Edwards Lifesciences's revenue?
Edwards Lifesciences had $6B in revenue for fiscal year 2024, up 11.5% from 2023. Net income was $1.4B.
- Latest revenue
- $6B (FY2024)
- Year-over-year
- +11.5%
- Growth rate (CAGR)
- 10.3% over 9 years
- Peak revenue
- $6B (FY2024)
- Years of data
- 10
- Employees
- 19,000
- How much profit does Edwards Lifesciences make?
- Edwards Lifesciences reported net income of $1.4B for fiscal year 2024.
- How many employees does Edwards Lifesciences have?
- Edwards Lifesciences has about 19,000 employees.
Financial Analysis
Edwards maintains an exceptional financial profile characterized by robust top-line revenue ($6.0B+), strong net margins (net income of $1.4B), and substantial cash reserves. The strategic divestiture of the Critical Care unit for $4.2B in 2024 further fortified the balance sheet, providing ample capital for targeted M&A and R&D acceleration in structural heart disease, heart failure management, and complex catheter-based interventions.
Revenue Trend Analysis
YoY Change
+11.5%
9-Year CAGR
+10.3%
Peak Year
2024
Trend
Consistent Growth
Edwards Lifesciences has 10 full fiscal year figures on this page, compounding at +10.3% annually over 9 years. The most recent year saw a 11.5% increase versus the prior year. Annual revenue peaked in fiscal year 2024 at $6B. Of 9 comparable year-over-year steps, 9 showed growth and 0 showed a decline.
Annual revenue history
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $6B | $1.4B | +11.5% |
| FY2023 | $5.4B | $1.3B | +0.3% |
| FY2022 | $5.4B | $1.4B | +2.5% |
| FY2021 | $5.2B | $1.5B | +19.3% |
| FY2020 | $4.4B | $1.1B | +0.3% |
| FY2019 | $4.4B | $1.2B | +15.6% |
| FY2018 | $3.8B | $820M | +11.2% |
| FY2017 | $3.4B | $710M | +14.1% |
| FY2016 | $3B | $650M | +19.8% |
| FY2015 | $2.5B | $510M | — |
Click any row to see year details.
Keep researching Edwards Lifesciences
Edwards Lifesciences Revenue and Financial FAQ
What was undefined's latest reported annual revenue?
In its latest audited financial reporting period, undefined recorded consolidated net revenue of undefined, demonstrating durable revenue growth across its primary operating divisions.
How profitable is undefined?
undefined generates industry-leading profitability, combining disciplined cost management with high gross margins to deliver substantial net earnings and superior return on equity (ROE) throughout changing economic cycles.
What is undefined's capital and liquidity position?
undefined maintains a fortress balance sheet equipped with ample liquid cash reserves, conservative debt leverage, and capital adequacy ratios that provide substantial safety margins above statutory regulatory requirements.
Does undefined distribute capital to shareholders?
undefined executes a disciplined capital allocation strategy that balances internal reinvestment into digital innovation and strategic growth with sustainable ordinary dividends and accretive share repurchase programs.
Cite or embed this data
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Edwards Lifesciences Revenue & Financials." CorpDigest, https://corpdigest.com/company/edwards-lifesciences/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Edwards Lifesciences reported $6B in revenue (FY2024).</strong><br>Source: <a href="https://corpdigest.com/company/edwards-lifesciences/financials" target="_blank" rel="noopener">CorpDigest — Edwards Lifesciences financials</a></div>Related Financial Audits
Compare revenue, net income, and market cap scale
Explore Edwards Lifesciences
Core profile pages, founders and related research hubs for this company.